CONGIA, MATTIA
 Distribuzione geografica
Continente #
EU - Europa 31.521
NA - Nord America 717
AS - Asia 194
Continente sconosciuto - Info sul continente non disponibili 1
Totale 32.433
Nazione #
IT - Italia 31.350
US - Stati Uniti d'America 711
CN - Cina 119
SE - Svezia 63
SG - Singapore 35
UA - Ucraina 27
DE - Germania 26
GB - Regno Unito 20
VN - Vietnam 20
FI - Finlandia 18
CA - Canada 6
KR - Corea 6
CZ - Repubblica Ceca 4
IL - Israele 4
IN - India 4
NL - Olanda 4
FR - Francia 3
IE - Irlanda 3
HK - Hong Kong 2
ID - Indonesia 2
IR - Iran 2
A1 - Anonimo 1
BG - Bulgaria 1
CH - Svizzera 1
RU - Federazione Russa 1
Totale 32.433
Città #
Cagliari 31.247
Chandler 95
Fairfield 87
Ashburn 57
Nyköping 57
Woodbridge 54
Houston 44
Shanghai 42
Boardman 38
Cambridge 33
Wilmington 32
Ann Arbor 30
Seattle 22
Boston 19
Dearborn 18
Dong Ket 18
Rome 17
Helsinki 16
Beijing 13
Guangzhou 11
Jacksonville 10
San Diego 10
Singapore 10
New York 9
London 7
Los Angeles 5
San Mateo 5
Sestu 5
Toronto 5
Kiryat Ono 4
Leawood 4
Milan 4
Redwood City 4
Seoul 4
Zola Predosa 4
Amsterdam 3
Brno 3
Changsha 3
Laurel 3
Licata 3
Mountain View 3
Nanjing 3
Phoenix 3
San Sperate 3
Wuhan 3
Alghero 2
Ardabil 2
Enna 2
Ferrara di Monte Baldo 2
Grumello Cremonese 2
Hanoi 2
Hebei 2
Hefei 2
Hyderabad 2
Jakarta 2
Mykolayiv 2
Nanchang 2
Ningbo 2
Norwalk 2
Rockville 2
Shenyang 2
Shenzhen 2
Tertenìa 2
Usellus 2
Wuxi 2
Xiamen 2
Acton 1
Bangalore 1
Caserta 1
Cherry Hill 1
Chicago 1
Chiswick 1
Chizhou 1
Dallas 1
Dublin 1
Elmas 1
Esslingen am Neckar 1
Gonnosfanàdiga 1
Handan 1
Honolulu 1
Hounslow 1
Indiana 1
Jesi 1
Jiaxing 1
Jinan 1
Kunming 1
La Maddalena 1
Monmouth Junction 1
Munich 1
New Bedfont 1
Oristano 1
Palermo 1
Paradiso 1
Piacenza 1
Prague 1
Quanzhou 1
Rignano 1
San Jose 1
Sassari 1
Scafati 1
Totale 32.146
Nome #
FRI0357 DRUG-INDUCED REMISSION AND SUBCLINICAL ACTIVITY IN PSORIATIC ARTHRITIS: TRANSCRIPTIONAL PROFILING TO CHARACTERIZE THE DISEASE STATE 6.746
Expression analysis of HLA-E and NKG2A and NKG2C receptors points at a role for natural killer function in ankylosing spondylitis 2.686
Assessment Of Circulating Endothelial Cells And Their Progenitors As Potential Biomarkers Of Disease Activity And Damage Accrual In Behçet's Syndrome 2.407
Musculoskeletal manifestations as determinants of quality of life impairment in patients with systemic lupus erythematosus 2.383
null 2.245
Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus 2.129
Gene expression profiling of monozygotic twins affected by psoriatic arthritis 2.069
null 1.791
Treatment target in newly diagnosed systemic lupus erythematosus: The association of lupus low disease activity state and remission with lower accrual of early damage 1.303
Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naïve to DMARDs: Results from a retrospective cohort study 1.101
Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis 811
Targeted Therapies in Axial Psoriatic Arthritis 760
Molecular profiling of clinical remission in psoriatic arthritis reveals dysregulation of FOS and CCDC50 genes: a gene expression study 622
Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review 620
Telemedicine in rheumatology: high specificity and sensitivity of follow-up virtual video consultations during COVID-19 pandemic 593
Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus 590
Patterns of Anti-Inflammatory and Immunomodulating Drug Usage and Microvascular Endothelial Function in Rheumatoid Arthritis 562
Imbalanced MMP-3 and MMP-12 serum levels in systemic lupus erythematosus patients with Jaccoud's arthropathy and a distinctive MRI pattern 560
SAT0035 IS PHARMACOLOGICAL CLINICAL REMISSION SYNONYMOUS WITH BIOLOGICAL INACTIVE DISEASE? DIFFERENTIAL GENE EXPRESSION ANALYSIS IN RHEUMATOID ARTHRITISAND HEALTY CONTROLS 407
Effect of anti-P ribosomal and anti-NR2 antibodies on depression and cognitive processes in SLE: an integrated clinical and functional MRI study 400
Ultrasonographic assessment of bone erosions in the different subtypes of systemic lupus erythematosus arthritis: Comparison with computed tomography 375
The Challenging Differentiation of Psoriatic Arthritis from Other Arthropathies and Nonspecific Arthralgias in Patients with Psoriasis: Results of a Cross-Sectional Rheumatologic Assessment of a Large Dermatologic Cohort 370
Predictors of musculoskeletal flares and Jaccoud׳s arthropathy in patients with systemic lupus erythematosus: A 5-year prospective study 312
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial 284
B Cell Synovitis and Clinical Phenotypes in Rheumatoid Arthritis: Relationship to Disease Stages and Drug Exposure 240
Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials 126
Treatment of psoriasis with different classes of biologics reduces the likelihood of peripheral and axial psoriatic arthritis development 60
Totale 32.552
Categoria #
all - tutte 39.642
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.642


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.788 0 93 24 54 1.328 1.274 578 109 67 69 57 135
2020/20216.006 157 209 172 2.160 1.112 568 310 302 191 325 333 167
2021/20222.284 175 102 71 88 177 131 92 137 231 279 432 369
2022/20233.526 333 525 414 300 307 405 183 247 211 228 238 135
2023/20246.285 177 188 203 447 578 653 665 1.890 242 269 525 448
2024/20258.338 7.943 395 0 0 0 0 0 0 0 0 0 0
Totale 32.552